Cholesteryl ester transfer protein protects against insulin resistance in obese female mice

Molecular Metabolism

Volumn 2, Issue 4, 2013, Pages 457-467

  Cappel, David A ^b   Palmisano, Brian T ^b   Emfinger, Christopher H ^a,b   Martinez, Melissa N ^b   McGuinness, Owen P ^b   Stafford, John M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bile; Cholesterol; Glucose; Insulin resistance; Obesity; Sex differences

Indexed keywords

BILE ACID; CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSE; INSULIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CETP GENE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIO2 GENE; FEMALE; FXR GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; GLYCOLYSIS; ILEUM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPID TRANSPORT; LIVER METABOLISM; MALE; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SHP GENE; TISSUE LEVEL;

MUS;

EID: 84889098151     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.08.007     Document Type: Article

References (48)

1. Wadden T.A. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Annals of Internal Medicine 1993, 119:688-693.
2. Wing R.R., Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition 2005, 82:222S-225S.
3. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 2009, 10:167-177.
4. Potthoff M.J., Boney-Montoya J., Choi M., He T., Sunny N.E., Satapati S., et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metabolism 2011, 13:729-738.
5. Kars M., Yang L., Gregor M.F., Mohammed B.S., Pietka T.A., Finck B.N., et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010, 59:1899-1905.
6. Rader D.J., Alexander E.T., Weibel G.L., Billheimer J., Rothblat G.H. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. Journal of Lipid Research 2009, 50:S189-S194.
7. Khera A.V., Cuchel M., de la Llera-Moya M., Rodrigues A., Burke M.F., Jafri K., et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New England Journal of Medicine 2011, 364:127-135.
8. Watanabe M., Morimoto K., Houten S.M., Kaneko-Iwasaki N., Sugizaki T., Horai Y., et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PloS One 2012, 7:e38286.
9. Potthoff M.J., Potts A., He T., Duarte J.A., Taussig R., Mangelsdorf D.J., et al. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. American Journal of Physiology - Gastrointestinal and Liver Physiology 2013, 304:G371-G380.
10. Beysen C., Murphy E.J., Deines K., Chan M., Tsang E., Glass A., et al. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study. Diabetologia 2012, 55:432-442.
11. Kir S., Beddow S.A., Samuel V.T., Miller P., Previs S.F., Suino-Powell K., et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 2011, 331:1621-1624.
12. Shin D.J., Osborne T.F. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. Journal of Biological Chemistry 2009, 284:11110-11120.
13. Maruyama T., Tanaka K., Suzuki J., Miyoshi H., Harada N., Nakamura T., et al. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. Journal of Endocrinology 2006, 191:197-205.
14. Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006, 439:484-489.
15. El Bouhassani M., Gilibert S., Moreau M., Saint-Charles F., Treguier M., Poti F., et al. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. Journal of Biological Chemistry 2011, 286:17227-17238.
16. Tanigawa H., Billheimer J.T., Tohyama J.I., Zhang Y.Z., Rothblat G., Rader D.J. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Circulation 2007, 116:1267-1273.
17. Marotti K.R., Castle C.K., Boyle T.P., Lin A.H., Murray R.W., Melchior G.W. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993, 364:73-75.
18. Marotti K.R., Castle C.K., Murray R.W., Rehberg E.F., Polites H.G., Melchior G.W. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice. Arteriosclerosis and Thrombosis 1992, 12:736-744.
19. Schwartz C.C., VandenBroek J.M., Cooper P.S. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. Journal of Lipid Research 2004, 45:1594-1607.
20. Ji Y., Wang N., Ramakrishnan R., Sehayek E., Huszar D., Breslow J.L., et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. Journal of Biological Chemistry 1999, 274:33398-33402.
21. Ayala J.E., Bracy D.P., Mcguinness O., Wasserman D.H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 2006, 55:390-397.
22. Berglund E.D., Li C.Y., Poffenberger G., Ayala J.E., Fueger P.T., Willis S.E., et al. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 2008, 57:1790-1799.
23. Zhu L., Brown W.C., Cai Q., Krust A., Chambon P., McGuinness O.P., et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 2013, 62:424-434.
24. Ayala J.E., Bracy D.P., Julien B.M., Rottman J.N., Fueger P.T., Wasserman D.H. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 2007, 56:1025-1033.
25. Martinez M.N., Emfinger C.H., Overton M.H., Hill S., Ramaswamy T.S., Cappel D.A., et al. Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones. Journal of Lipid Research 2012, 53:379-389.
26. de Aguiar Vallim T.Q., Tarling E.J., Edwards P.A. Pleiotropic roles of bile acids in metabolism. Cell Metabolism 2013, 17:657-669.
27. Zander M., Madsbad S., Madsen J.L., Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002, 359:824-830.
28. Wang Q., Brubaker P.L. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 2002, 45:1263-1273.
29. Poole D.P., Godfrey C., Cattaruzza F., Cottrell G.S., Kirkland J.G., Pelayo J.C., et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 2010, 22(814-25):e227-e228.
30. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J., Komajda M., et al. Effects of torcetrapib in patients at high risk for coronary events. New England Journal of Medicine 2007, 357:2109-2122.
31. Schwartz G.G., Olsson A.G., Abt M., Ballantyne C.M., Barter P.J., Brumm J., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England Journal of Medicine 2012, 367:2089-2099.
32. Asztalos B.F., Swarbrick M.M., Schaefer E.J., Dallal G.E., Horvath K.V., Ai M., et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. Journal of Lipid Research 2010, 51:2405-2412.
33. Purnell J.Q., Kahn S.E., Albers J.J., Nevin D.N., Brunzell J.D., Schwartz R.S. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. Journal of Clinical Endocrinology & Metabolism 2000, 85:977-982.
34. Barter P.J., Rye K.A., Tardif J.C., Waters D.D., Boekholdt S.M., Breazna A., et al. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation 2011, 124:555-562.
35. Dullaart R.P., Sluiter W.J., Dikkeschei L.D., Hoogenberg K., Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. European Journal of Clinical Investigation 1994, 24:188-194.
36. Maclean P. Plasma cholesteryl ester transfer protein activity is not linked to insulin sensitivity. Metabolism 2001, 50:783-788.
37. Villard E.F., El Khoury P., Duchene E., Bonnefont-Rousselot D., Clement K., Bruckert E., et al. Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:2341-2349.
38. Villard E.F., Khoury P.E., Frisdal E., Bruckert E., Clement K., Bonnefont-Rousselot D., et al. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arteriosclerosis, Thrombosis, and Vascular Biology 2013.
39. Agerholm-Larsen B., Tybjaerg-Hansen A., Schnohr P., Steffensen R., Nordestgaard B.G. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: the Copenhagen City Heart Study. Circulation 2000, 102:2197-2203.
40. Wang H.H., Afdhal N.H., Wang D.Q. Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. Journal of Lipid Research 2006, 47:778-786.
41. Hayek T., Azrolan N., Verdery R.B., Walsh A., Chajek-Shaul T., Agellon L.B., et al. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. Journal of Clinical Investigation 1993, 92:1143-1152.
42. Lai K., Harnish D.C., Evans M.J. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. Journal of Biological Chemistry 2003, 278:36418-36429.
43. Gong M., Wilson M., Kelly T., Su W., Dressman J., Kincer J., et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. Journal of Clinical Investigation 2003, 111:1579-1587.
44. Provost P.R., Lavallee B., Belanger A. Transfer of dehydroepiandrosterone- and pregnenolone-fatty acid esters between human lipoproteins. Journal of Clinical Endocrinology and Metabolism 1997, 82:182-187.
45. Gauthier A., Lau P., Zha X., Milne R., McPherson R. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:2177-2184.
46. Vassiliou G., McPherson R. Role of cholesteryl ester transfer protein in selective uptake of high density lipoprotein cholesteryl esters by adipocytes. Journal of Lipid Research 2004, 45:1683-1693.
47. Niesor E.J., Magg C., Ogawa N., Okamoto H., von der Mark E., Matile H., et al. Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport. Journal of Lipid Research 2010, 51:3443-3454.
48. Castro-Perez J., Briand F., Gagen K., Wang S.P., Chen Y., McLaren D.G., et al. Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters. Journal of Lipid Research 2011, 52:1965-1973.